000 | 01560 a2200433 4500 | ||
---|---|---|---|
005 | 20250515065700.0 | ||
264 | 0 | _c20070802 | |
008 | 200708s 0 0 eng d | ||
022 | _a1401-7431 | ||
024 | 7 |
_a10.1080/14017430601137160 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBredin, Fredrik | |
245 | 0 | 0 |
_aExperiences of levosimendan as an inotropic agent in conjunction with passive containment surgery. _h[electronic resource] |
260 |
_bScandinavian cardiovascular journal : SCJ _cJun 2007 |
||
300 |
_a197-200 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCardiac Output _xdrug effects |
650 | 0 | 4 | _aCardiac Surgical Procedures |
650 | 0 | 4 |
_aCardiomyopathy, Dilated _xdrug therapy |
650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHeart-Assist Devices |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrazones _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPyridazines _xadministration & dosage |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSimendan |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aFranco-Cereceda, Anders | |
773 | 0 |
_tScandinavian cardiovascular journal : SCJ _gvol. 41 _gno. 3 _gp. 197-200 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/14017430601137160 _zAvailable from publisher's website |
999 |
_c17033848 _d17033848 |